Noutati

Complicatiile in epilarea laser in Dermatologic Therapy (Wiley)

Experienta Zilelor Dermatologiei la Sibiu, 2020

Articol recenzie sistematica Journal of Clinical Medicine

Experienta 28th EADV Congress, Madrid

Curcubeul in dermatoscopie – articol review ADC

Curs chirurgie micrografica Mohs

Articol original in Journal of Clinical Medicine – MDPI

Recenzie – vascularizatia carcinomului bazocelular (Spandidos Publications)

Mediators of Inflammation in Topical Therapy of Skin Cancers – Review article

O noua varianta de sindrom autoimun multiplu?

Rolul tehnicilor imagistice neinvazive in diagnosticul in vivo al lichenului plan

Interviu 27th EADV Congress, Paris

Articol in Romanian Journal of Morphology and Embriology

Case report in Molecular and Clinical Oncology

Premiu in cadrul Congresului National de Dermatologie al SRD

Lucrare Poster CND 2017, Brasov

Lucrare poster in cadrul ESDR 2017, Salzburg

Congresul National de Dermatologie cu participare internationala, Octombrie 2017, Brasov

Articol prezentare de caz – Macedonian Journal of Medical Sciences

Articol de review Oncology Reports

Conferinta Nationala cu participare Internationala “Zilele Gh. Nastase”, Mai 2017, Iasi

Articole premiate UEFISCDI

Serie de articole “Minutul de sanatate” la EuropaFM

Topical Tacrolimus and Malignancy Risk: Should the Theory Be Put to Rest? mai 29, 2020
Warren R. Heymann
The title of the paper: Treatment of painful and deep fissures of heel with topical timolol mai 29, 2020
Manoj Pawar
Bimekizumab for patients with moderate-to-severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled phase 2b extension study mai 28, 2020
• In the BE ABLE 2 study, bimekizumab demonstrated high response rates maintained through week 60, with a substantial proportion achieving complete skin clearance, and was generally well tolerated. • These data further support dual neutralization of IL-17A and IL-17F with bimekizumab as a novel therapeutic approach for patients with psoriasis.
Andrew Blauvelt, Kim A. Papp, Joseph F. Merola, Alice B. Gottlieb, Nancy Cross, Cynthia Madden, Maggie Wang, Christopher Cioffi, Christopher E.M. Griffiths
Tofacitinib in the treatment of lichen planopilaris: a retrospective review mai 28, 2020
John Plante, Chelsea Eason, Alan Snyder, Dirk Elston
Efficacy of Staged Excision with Permanent Section Margin Control for Melanoma In Situ mai 28, 2020
H. Harris Reynolds, Eugen Stancut, Peter G. Pavlidakey, Conway C. Huang, C. Blake Phillips
One-year real-world clinical effectiveness, safety and laboratory safety of dupilumab in Japanese adult patients with atopic dermatitis: A single-center retrospective study mai 28, 2020
Hideaki Uchida, Masahiro Kamata, Aika Kato, Itsumi Mizukawa, Ayu Watanabe, Ai Agematsu, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada
Easy way of making blister in suction blister grafting of vitiligo with ‘Hijama’ therapy cups. mai 23, 2020
Saurabh Jain, Suman Patra, Sanjeev Choudhary, Maninder Kaur
Prurigo Nodularis: Epidemiology and Clinical Features mai 23, 2020
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by intensely pruritic, hyperkeratotic nodules that favor the extensor surfaces of the extremities and the trunk. In addition to its significant impact on quality of life, many patients with PN are recalcitrant to therapy as there are currently no FDA approved therapies.In the first article […]
Amy H. Huang, Kyle A. Williams, Shawn G. Kwatra
Prurigo Nodularis: Pathogenesis and Management mai 23, 2020
Prurigo nodularis (PN) is a chronic skin condition characterized by severely pruritic nodules that cause a profound negative impact on quality of life. In the second article of this 2-part continuing medical education series, we focus on reviewing pathogenesis of prurigo nodularis and explore management algorithms for this condition. Additionally, we will discuss some emerging […]
Kyle A. Williams, Amy H. Huang, Micah Belzberg, Shawn G. Kwatra
Comment on “Re-Evaluating the ABCD Criteria Using a Consecutive Series of Melanomas” mai 23, 2020
Stuart Martin Goldsmith